Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Change in Receivables (2016 - 2025)

Historic Change in Receivables for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to $456916.0.

  • cbdMD's Change in Receivables rose 50516.27% to $456916.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $439565.0, marking a year-over-year increase of 34714.38%. This contributed to the annual value of $439565.0 for FY2025, which is 34714.38% up from last year.
  • Per cbdMD's latest filing, its Change in Receivables stood at $456916.0 for Q3 2025, which was up 50516.27% from -$84759.0 recorded in Q2 2025.
  • cbdMD's 5-year Change in Receivables high stood at $1.0 million for Q1 2021, and its period low was -$815369.0 during Q2 2022.
  • Its 5-year average for Change in Receivables is $11131.1, with a median of -$49813.0 in 2023.
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 1354446.58% in 2021, then tumbled by 1195777.34% in 2022.
  • Quarter analysis of 5 years shows cbdMD's Change in Receivables stood at -$4554.0 in 2021, then plummeted by 11957.77% to -$549111.0 in 2022, then surged by 87.77% to -$67169.0 in 2023, then skyrocketed by 530.16% to $288936.0 in 2024, then surged by 58.14% to $456916.0 in 2025.
  • Its Change in Receivables was $456916.0 in Q3 2025, compared to -$84759.0 in Q2 2025 and -$221528.0 in Q1 2025.